What is Duke Extrusion?
Duke Extrusion operates as a premier full-service contract manufacturer, delivering high-performance medical-grade tubing and complex catheter assemblies. The company serves as a vital partner for medical device manufacturers and OEMs, providing end-to-end product and process solutions. By prioritizing innovation and rapid prototyping, Duke Extrusion effectively reduces the time-to-market for sophisticated medical devices. Their technical expertise in extrusion processes allows them to meet stringent regulatory requirements while maintaining the precision necessary for life-critical medical applications. As a key player in the healthcare infrastructure, the firm bridges the gap between raw material engineering and final clinical deployment.
How much funding has Duke Extrusion raised?
Duke Extrusion has raised a total of $1.1M across 2 funding rounds:
Debt
$350K
Debt
$773K
Debt (2020): $350K with participation from PPP
Debt (2021): $773K led by PPP
Key Investors in Duke Extrusion
PPP
Public-Private Partnership
What's next for Duke Extrusion?
With the recent influx of capital, Duke Extrusion is positioned to accelerate its manufacturing capabilities and expand its footprint in the global medical device market. The strategic allocation of these funds will likely focus on scaling production infrastructure, enhancing R&D for next-generation catheter technologies, and optimizing supply chain resilience. As the demand for minimally invasive surgical tools continues to rise, the company is well-equipped to leverage its current financial stability to capture additional market share. Future growth will likely be driven by deepening partnerships with major OEMs and investing in advanced material science to maintain a competitive edge in the high-barrier-to-entry medical manufacturing landscape.
See full Duke Extrusion company page
